Published in
American Association for the Advancement of Science, Science Translational Medicine, 696(15), 2023
DOI: 10.1126/scitranslmed.adh0604
Links
Tools
Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”
Journal article published in 2023 by
Eduardo A. Albornoz 
,
Richard Gordon ,
Vinod Kumar ,
Avril A. B Robertson ,
Kate Schroder ,
Trent M. Woodruff
,
Richard Gordon ,
Vinod Kumar ,
Avril A. B Robertson ,
Kate Schroder ,
Trent M. Woodruff
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
We have replicated our original finding of elevated cleaved caspase-1 in mouse brains and neuroprotection by an NLRP3 inflammasome inhibitor in two mouse models of Parkinson’s disease.